The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126953122 12695312 2 F 20160902 20160829 20160916 EXP US-UCBSA-2016032553 UCB MCNALLY MA, JOHNSON J, HUISMAN TAGM, PORETTI A, BARANANO K, BASCHAT AA, ET AL. TREATMENT OF FETAL SEIZURES/ SCN8A EPILEPTIC ENCEPHALOPATHY: DETECTION OF FETAL SEIZURES GUIDES MULTIDISCIPLINARY APPROACH TO DIAGNOSIS AND TREATMENT. PEDIATRIC NEUROLOGY. 2016 0.00 F Y 4.00000 KG 20160916 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126953122 12695312 1 PS LEVETIRACETAM. LEVETIRACETAM 1 Transplacental 500 MG, 2X/DAY (BID) U U 21035 500 MG BID
126953122 12695312 2 SS LEVETIRACETAM. LEVETIRACETAM 1 Transplacental 500 MG, 3X/DAY (TID) U U 21035 500 MG TID
126953122 12695312 3 SS LEVETIRACETAM. LEVETIRACETAM 1 Transplacental 750 MG, 3X/DAY (TID) U U 21035 750 MG TID
126953122 12695312 4 SS LEVETIRACETAM. LEVETIRACETAM 1 UNKNOWN DOSE INITIATED AFTER BIRTH U U 21035
126953122 12695312 5 SS LEVETIRACETAM. LEVETIRACETAM 1 UNKNOWN DOSE TITRATION U U 21035
126953122 12695312 6 SS LEVETIRACETAM. LEVETIRACETAM 1 60 MG/KG/DAY U U 21035
126953122 12695312 7 C PHENOBARBITAL. PHENOBARBITAL 1 Intravenous (not otherwise specified) 20 MG/KG U U 0
126953122 12695312 8 C PHENOBARBITAL. PHENOBARBITAL 1 6 MG/KG/DAY U U 0 6 MG/KG
126953122 12695312 9 C OXCARBAZEPINE. OXCARBAZEPINE 1 UNKNOWN U 0
126953122 12695312 10 C OXCARBAZEPINE. OXCARBAZEPINE 1 TITRATED TO HIGH DOSE (80 MG/KG/DAY) U 0 80 MG/KG
126953122 12695312 11 C PHENYTOIN. PHENYTOIN 1 UNK U U 0
126953122 12695312 12 C LAMOTRIGINE. LAMOTRIGINE 1 UNK U U 0
126953122 12695312 13 C LAMOTRIGINE. LAMOTRIGINE 1 SLOWLY UPTITRATED TO 2 MG/KG/DAY U U 0 2 MG/KG
126953122 12695312 14 C DIAZEPAM. DIAZEPAM 1 Rectal UNK U U 0
126953122 12695312 15 C INDOMETHACIN. INDOMETHACIN 1 Transplacental UNKNOWN DOSE U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126953122 12695312 1 Seizure
126953122 12695312 7 Seizure
126953122 12695312 9 Seizure
126953122 12695312 11 Seizure
126953122 12695312 12 Seizure
126953122 12695312 14 Seizure
126953122 12695312 15 Polyhydramnios

Outcome of event

Event ID CASEID OUTC COD
126953122 12695312 OT
126953122 12695312 HO
126953122 12695312 CA

Reactions reported

Event ID CASEID DRUG REC ACT PT
126953122 12695312 Cardiomegaly
126953122 12695312 Congenital multiplex arthrogryposis
126953122 12695312 Deformity of orbit
126953122 12695312 Foetal exposure during pregnancy
126953122 12695312 Foetal macrosomia
126953122 12695312 Generalised oedema
126953122 12695312 Hand deformity
126953122 12695312 High arched palate
126953122 12695312 Hypotonia
126953122 12695312 Joint contracture
126953122 12695312 Low set ears
126953122 12695312 Nervous system disorder
126953122 12695312 Oxygen saturation decreased
126953122 12695312 Seizure
126953122 12695312 Tachycardia
126953122 12695312 Tardive dyskinesia
126953122 12695312 Tonic convulsion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found